Effects of ocular administration of ophthalmic 2% dorzolamide hydrochloride solution on aqueous humor flow rate and intraocular pressure in clinically normal cats

Amy J. Rankin Department of Veterinary Clinical Sciences, Kansas State University, College of Veterinary Medicine, Manhattan, KS 66506.

Search for other papers by Amy J. Rankin in
Current site
Google Scholar
PubMed
Close
 DVM, MS
,
William R. Crumley Department of Veterinary Clinical Sciences, Kansas State University, College of Veterinary Medicine, Manhattan, KS 66506.

Search for other papers by William R. Crumley in
Current site
Google Scholar
PubMed
Close
 DVM, MS
, and
Rachel A. Allbaugh Department of Veterinary Clinical Sciences, Kansas State University, College of Veterinary Medicine, Manhattan, KS 66506.

Search for other papers by Rachel A. Allbaugh in
Current site
Google Scholar
PubMed
Close
 DVM, MS

Abstract

Objective—To determine the effects of ocular administration of ophthalmic 2% dorzolamide hydrochloride solution on aqueous humor flow rate (AHFR) and intraocular pressure (IOP) in clinically normal cats.

Animals—20 clinically normal domestic shorthair cats.

Procedures—Following an acclimation period, IOP was measured in each eye of all cats 5 times daily for 3 days to determine baseline values. Fifteen cats received 1 drop of 2% dorzolamide solution and 5 cats received 1 drop of control solution in each eye every 8 hours for 5 days (treatment phase). The IOP of each eye was measured 5 times during each day of the treatment phase. Prior to and after the treatment phase, AHFR in both eyes of each cat was measured via fluorophotometry.

Results—Prior to treatment, AHFR or IOP did not differ between the treatment and control groups. In dorzolamide-treated cats, mean AHFR after the treatment phase (3.47 ± 1.5 μL/min) was significantly lower than the value prior to treatment (5.90 ± 2.2 μL/min) and mean IOP during the treatment phase (11.1 ± 1.0 mm Hg) was significantly lower than the baseline mean IOP (14.9 ± 1.0 mm Hg). In the control group, IOP values did not differ before or during the treatment phase and AHFRs did not differ before and after the treatment phase.

Conclusions and Clinical Relevance—Ocular administration of 2% dorzolamide solution significantly decreased AHFR and IOP in clinically normal cats. Application of 2% dorzolamide solution may be an effective treatment in cats with glaucoma.

Abstract

Objective—To determine the effects of ocular administration of ophthalmic 2% dorzolamide hydrochloride solution on aqueous humor flow rate (AHFR) and intraocular pressure (IOP) in clinically normal cats.

Animals—20 clinically normal domestic shorthair cats.

Procedures—Following an acclimation period, IOP was measured in each eye of all cats 5 times daily for 3 days to determine baseline values. Fifteen cats received 1 drop of 2% dorzolamide solution and 5 cats received 1 drop of control solution in each eye every 8 hours for 5 days (treatment phase). The IOP of each eye was measured 5 times during each day of the treatment phase. Prior to and after the treatment phase, AHFR in both eyes of each cat was measured via fluorophotometry.

Results—Prior to treatment, AHFR or IOP did not differ between the treatment and control groups. In dorzolamide-treated cats, mean AHFR after the treatment phase (3.47 ± 1.5 μL/min) was significantly lower than the value prior to treatment (5.90 ± 2.2 μL/min) and mean IOP during the treatment phase (11.1 ± 1.0 mm Hg) was significantly lower than the baseline mean IOP (14.9 ± 1.0 mm Hg). In the control group, IOP values did not differ before or during the treatment phase and AHFRs did not differ before and after the treatment phase.

Conclusions and Clinical Relevance—Ocular administration of 2% dorzolamide solution significantly decreased AHFR and IOP in clinically normal cats. Application of 2% dorzolamide solution may be an effective treatment in cats with glaucoma.

Contributor Notes

Dr. Crumley's present address is Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Dr. Allbaugh's present address is Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011.

Supported by a Kansas State University Small Research Grant.

Presented in part at the 41st Annual American College of Veterinary Ophthalmology Meeting, San Diego, October 2010.

Address correspondence to Dr. Rankin (arankin@vet.k-state.edu).
  • 1. Gum G, Gelatt K, Esson D. Physiology of the eye. In: Gelatt K, ed. Veterinary ophthalmology. 4th ed. Ames, Iowa: Blackwell Publishing, 2007;149182.

    • Search Google Scholar
    • Export Citation
  • 2. Menabuoni L, Scozzafava A, Mincione F, et al. Carbonic anhydrase inhibitors. Water-soluble, topically effective intraocular pressure lowering agents derived from isonicotinic acid and aromatic/heterocyclic sulfonamides: is the tail more important that the ring? J Enzyme Inhib 1999; 14:457474.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3. Dodgson S. The carbonic anhydrases: overview of their importance in cellular physiology and in molecular genetics. In: Dodgson S, Tashian R, Gros G, et al, eds. The carbonic anhydrases: cellular physiology and molecular genetics. New York: Plenum Press, 1991;314.

    • Search Google Scholar
    • Export Citation
  • 4. Jampel H, Chen X, Chue C, et al. Expression of carbonic anhydrase isozyme III in the ciliary processes and lens. Invest Ophthalmol Vis Sci 1997; 38:539543.

    • Search Google Scholar
    • Export Citation
  • 5. Ridderstrale Y, Wistrand P, Brechue W. Membrane-associated CA activity in the eye of the CA II-deficient mouse. Invest Ophthalmol Vis Sci 1994; 35:25772584.

    • Search Google Scholar
    • Export Citation
  • 6. Brechue W, Maren T. A comparison between the effects of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion. Exp Eye Res 1993; 57:6778.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7. Regnier A. Clinical pharmacology and therapeutics In: Gelatt K, ed. Veterinary ophthalmology. 4th ed. Ames, Iowa: Blackwell Publishing, 2007;288331.

    • Search Google Scholar
    • Export Citation
  • 8. Epstein D, Grant W. Carbonic anhydrase inhibitor side effects serum chemical analysis. Arch Ophthalmol 1977; 95:13781382.

  • 9. Lichter P, Newman L, Wheeler N, et al. Patient tolerance to carbonic anhydrase inhibitors. Am J Ophthalmol 1978; 85:495502.

  • 10. Mogk L, Cyrlin M. Blood dyscrasias and carbonic anhydrase inhibitors. Ophthalmology 1988; 95:768771.

  • 11. Gwin R. Current concepts in small animal glaucoma: recognition and treatment. Vet Clin North Am Small Anim Pract 1980; 10:357376.

  • 12. Cawrse MA, Ward DA, Hendrix DV. Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs. Am J Vet Res 2001; 62:859863.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13. Reitsamer H, Bogner B, Tockner B, et al. Effects of dorzolamide on choroidal blood flow, ciliary blood flow, and aqueous production in rabbits. Invest Ophthalmol Vis Sci 2009; 50:23012307.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14. Willis AM, Robbin TE, Hoshaw-Woodard S, et al. Effect of topical administration of 2% dorzlamide hydrochloride or 2% dorzlamide hydrochloride-0.5% timolol maleate on intraocular pressure in clinically normal horses. Am J Vet Res 2001; 62:709713.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15. Gelatt K, MacKay E. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs. Vet Ophthalmol 2001; 4:6167.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16. Sugrue M. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. J Ocul Pharmacol Ther 1996; 12:363376.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17. Rainbow M, Dziezyc J. Effects of twice daily application of 2% dorzolamide on intraocular pressure in normal cats. Vet Ophthalmol 2003; 6:147150.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18. Dietrich U, Chandler M, Cooper T, et al. Effects of topical 2% dorzolamide hydrochloride alone and in combination with 0.5% timolol maleate on intraocular pressure in normal feline eyes. Vet Ophthalmol 2007; 10:93100.

    • Search Google Scholar
    • Export Citation
  • 19. Sigle K, Camano-Garcia G, Carriquiry A, et al. The effect of dorzolamide 2% on circadian intraocular pressure in cats with primary congenital glaucoma. Vet Ophthalmol 2011; 14:4853.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20. Tsukamoto H, Larsson L. Aqueous humor flow in normal human eyes treated with brimonidine and dorzolamide, alone and in combination. Arch Ophthalmol 2004; 122:190193.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21. Wayman L, Larsson L, Maus T, et al. Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans. Arch Ophthalmol 1997; 115:13681371.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22. Yamazaki Y, Miyamoto S, Sawa M. Effect of MK-507 on aqueous humor dynamics in normal human eyes. Jpn J Ophthalmol 1994; 38:9296.

  • 23. Wang R, Serle J, Podos S, et al. MK-507 (L-671, 152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys. Arch Ophthalmol 1991; 109:12971299.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24. Yablonski ME, Zimmerman TJ, Waltman SR, et al. A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp Eye Res 1978; 27:135142.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25. Jones R, Maurice D. New methods of measuring the rate of aqueous flow in man with fluorescein. Exp Eye Res 1966; 5:208220.

  • 26. Ward DA, Cawrse MA, Hendrix DV. Fluorophotometric determination of aqueous humor flow rate in clinically normal dogs. Am J Vet Res 2001; 62:853858.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27. Crumley WR, Rankin AJ, Allbaugh RA. Evaluation of the aqueous humor flow rate in the eyes of clinically normal cats by use of fluorophotometry. Am J Vet Res 2012; 73:704708.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28. Skorobohach BJ, Ward DA, Hendrix DVH. Effects of oral administration of methazolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs. Am J Vet Res 2003; 64:183187.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29. van Best J, Boets E, Stolwijk T. Simultaneous determination of corneal endothelial permeability value and anterior chamber flow. In: Cunha-Vaz JG, Leite E, Ramos MC, eds. Manual of ocular fluorophotometry. Coimbra, Portugal: Coimbra Editora, 1993;5167.

    • Search Google Scholar
    • Export Citation
  • 30. Kafarnik C, Fritsche J, Reese S. In vivo confocal microscopy in the normal corneas of cats, dogs, and birds. Vet Ophthalmol 2007; 10:222230.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31. Toris C, Yablonski M, Wang Y, et al. Prostaglandin A2 increases uveoscleral outflow and trabecular outflow facility in the cat. Exp Eye Res 1995; 61:649657.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32. Vanlandingham B, Maus T, Brubaker R. The effect of dorzolamide on aqueous humor dynamics in normal human subjects during sleep. Ophthalmology 1998; 105:15371540.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33. Bloom J, Levene R, Tomas G, et al. Fluorophotometry and the rate of aqueous flow in man. I. Instrumentation and normal values. Arch Ophthalmol 1976; 94:435443.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34. Coakes R, Brubaker R. Method of measuring aqueous humor flow and corneal endothelial permeability using a fluorophotometry nomogram. Invest Ophthalmol Vis Sci 1979; 18:288302.

    • Search Google Scholar
    • Export Citation
  • 35. Rusanen E, Florin M, Hassig M, et al. Evaluation of a rebound tonometer (TonoVet) in clinically normal cat eyes. Vet Ophthalmol 2010; 13:3136.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36. Görig C, Coenen RT, Stades FC, et al. Comparison of the use of new handheld tonometers and established applanation tonometers in dogs. Am J Vet Res 2006; 67:134144.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37. Gelatt KN, Gum G, Williams LW, et al. Ocular hypotensive effects of carbonic anhydrase inhibitors in normotensive and glaucomatous Beagles. Am J Vet Res 1979; 40:334345.

    • Search Google Scholar
    • Export Citation
  • 38. King TC, Gum GG, Gelatt KN. Evaluation of a topically administered carbonic anhydrase inhibitor (MK-927) in normotensive and glaucomatous Beagles. Am J Vet Res 1991; 52:20672070.

    • Search Google Scholar
    • Export Citation

Advertisement